This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University System of Maryland. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Lijia Chen: Innovator in Cancer Treatment
Introduction: Lijia Chen is a notable inventor based in Columbia, MD (US). He has made significant contributions to the field of cancer research, particularly through his work on small molecule inhibitors.
Latest Patents: Lijia Chen holds a patent for "Small molecule inhibitors of the MCL-1 oncoprotein and uses thereof." This patent involves compounds that inhibit Myeloid Cell Leukemia-1 (Mcl-1) oncoprotein, providing methods for treating various diseases.
Career Highlights: Lijia Chen is affiliated with the University System of Maryland, where he continues to advance his research and innovation in the medical field. His work has the potential to impact cancer treatment significantly.
Collaborations: Lijia has collaborated with esteemed colleagues, including Steven Fletcher and Maryanna Lanning, who contribute to his research endeavors.
Conclusion: Lijia Chen's innovative work in developing inhibitors for cancer treatment showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against cancer.